Complete Spontaneous Regression of Lung Adenocarcinoma With No Residual Malignancy After Surgical Resection: A Case Report

Clinical Lung Cancer · Published 2026-05-26 · DOI 10.1016/j.cllc.2026.05.007

Free full text

Authors (5)

Anders Näslund, Hans Brunnström, Jesper Andreasson, Marija Karadzovska-Kotevska, Hamid Akbarshahi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Näslund, A., Brunnström, H., Andreasson, J., et al. (2026). Complete Spontaneous Regression of Lung Adenocarcinoma With No Residual Malignancy After Surgical Resection: A Case Report. Clinical Lung Cancer. https://doi.org/10.1016/j.cllc.2026.05.007

Related articles

• Poor Performance Status Associated With Inferior Tarlatamab Outcomes in a Large, Multi-institution Real-World Database of Patients With 2L + ES-SCLC · Clinical Lung Cancer · 2026 · Same journal
• Real-World Safety and Effectiveness of Neoadjuvant Chemoimmunotherapy in Squamous Cell Lung Cancer: A Retrospective European Multicentre Study · Clinical Lung Cancer · 2026 · Same journal
• Next-Generation Sequencing Completion and Timeliness Using a Reflex Testing Protocol for Patients with Stage II to IV Nonsquamous Non–Small Cell Lung Cancer · Clinical Lung Cancer · 2026 · Same journal
• Brief Report: A Pilot Study Evaluating the Feasibility, Safety, and Compliance With a Fasting-Mimicking Diet in Patients With Metastatic Non–Small Cell Lung Cancer · Clinical Lung Cancer · 2026 · Same journal
• Clinicogenomic Predictors of First-line Immune Checkpoint Inhibitor Outcomes in Non–Small Cell Lung Cancer: A Nationwide C CAT Cohort From Japan · Clinical Lung Cancer · 2026 · Same journal
• Streamlining the Frequency, Conduct, and Location of Assessments in Registrational Lung Cancer Clinical Trials for Supplemental Applications: Recommendations of a LUNGevity Foundation Multistakeholder Working Group · Clinical Lung Cancer · 2026 · Same journal
• Impact of Programmed Death Ligand 1 Expression on Outcomes in Stage I-II Epidermal Growth Factor Receptor-Mutant Lung Adenocarcinoma · Clinical Lung Cancer · 2026 · Same journal
• Consolidative Radiotherapy for Extensive-Stage Small Cell Lung Cancer: Outcomes Based on Completeness of Consolidation and Oligometastatic State · Clinical Lung Cancer · 2026 · Same journal
• Adjuvant Therapy After Pathologic Complete Response to Neoadjuvant Immunochemotherapy in Non–Small Cell Lung Cancer: A Multicenter Retrospective Real-World Study · Clinical Lung Cancer · 2026 · Same journal
• Dosimetric Predictors of Radiation Pneumonitis for Stage III NSCLC Treated With Neoadjuvant Immuno-chemotherapy and Definitive Chemoradiation: A Multi-institutional Analysis · Clinical Lung Cancer · 2026 · Same journal